Topographic staging of tau positron emission tomography images

It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one samplin...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia : diagnosis, assessment & disease monitoring Vol. 10; no. 1; pp. 221 - 231
Main Authors Schwarz, Adam J., Shcherbinin, Sergey, Slieker, Lawrence J., Risacher, Shannon L., Charil, Arnaud, Irizarry, Michael C., Fleisher, Adam S., Southekal, Sudeepti, Joshi, Abhinay D., Devous, Michael D., Miller, Bradley B., Saykin, Andrew J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 2018
Elsevier
Wiley
Subjects
Alzheimer
AV-1451
Braak
Classification
Flortaucipir
PET
Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Stage
Staging
T807
Tau
AV-1451
Flortaucipir
Staging
Classification
Tau
Stage
Image
Braak
T807
Alzheimer
PET
Online AccessGet full text

Cover

Abstract It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.
AbstractList It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage. Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.
It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology.INTRODUCTIONIt has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology.Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2.METHODSThree topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test-retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2.All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage.RESULTSAll three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test-retest reproducibility of assigned stage.Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.DISCUSSIONTau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.
Abstract Introduction It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test‐retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test‐retest reproducibility of assigned stage. Discussion Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.
Introduction It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those seen in neuropathology. Methods Three topographic staging schemes for tau PET, two sampling the temporal and occipital subregions only and one sampling cortical gray matter across the major brain lobes, were evaluated on flortaucipir F 18 PET images in a test‐retest scenario and from Alzheimer's Disease Neuroimaging Initiative 2. Results All three schemes estimated stages that were significantly associated with amyloid status and when dichotomized to tau positive or negative were 90% to 94% concordant in the populations identified. However, the schemes with fewer regions and simpler decision rules yielded more robust performance in terms of fewer unclassified scans and increased test‐retest reproducibility of assigned stage. Discussion Tau PET staging schemes could be useful tools to concisely index the regional involvement of tau pathology in living subjects. Simpler schemes may be more robust.
Author Risacher, Shannon L.
Saykin, Andrew J.
Southekal, Sudeepti
Slieker, Lawrence J.
Miller, Bradley B.
Shcherbinin, Sergey
Devous, Michael D.
Fleisher, Adam S.
Charil, Arnaud
Irizarry, Michael C.
Joshi, Abhinay D.
Schwarz, Adam J.
AuthorAffiliation c Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA
d Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN, USA
e Avid Radiopharmaceuticals (a Wholly Owned Subsidiary of Eli Lilly and Company), Philadelphia, PA, USA
a Eli Lilly and Company, Indianapolis, IN, USA
b Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
AuthorAffiliation_xml – name: a Eli Lilly and Company, Indianapolis, IN, USA
– name: c Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA
– name: e Avid Radiopharmaceuticals (a Wholly Owned Subsidiary of Eli Lilly and Company), Philadelphia, PA, USA
– name: b Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
– name: d Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN, USA
Author_xml – sequence: 1
  givenname: Adam J.
  surname: Schwarz
  fullname: Schwarz, Adam J.
  email: a.schwarz@lilly.com
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 2
  givenname: Sergey
  surname: Shcherbinin
  fullname: Shcherbinin, Sergey
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 3
  givenname: Lawrence J.
  surname: Slieker
  fullname: Slieker, Lawrence J.
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 4
  givenname: Shannon L.
  surname: Risacher
  fullname: Risacher, Shannon L.
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
– sequence: 5
  givenname: Arnaud
  surname: Charil
  fullname: Charil, Arnaud
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 6
  givenname: Michael C.
  surname: Irizarry
  fullname: Irizarry, Michael C.
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 7
  givenname: Adam S.
  surname: Fleisher
  fullname: Fleisher, Adam S.
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 8
  givenname: Sudeepti
  surname: Southekal
  fullname: Southekal, Sudeepti
  organization: Avid Radiopharmaceuticals (a Wholly Owned Subsidiary of Eli Lilly and Company), Philadelphia, PA, USA
– sequence: 9
  givenname: Abhinay D.
  surname: Joshi
  fullname: Joshi, Abhinay D.
  organization: Avid Radiopharmaceuticals (a Wholly Owned Subsidiary of Eli Lilly and Company), Philadelphia, PA, USA
– sequence: 10
  givenname: Michael D.
  surname: Devous
  fullname: Devous, Michael D.
  organization: Avid Radiopharmaceuticals (a Wholly Owned Subsidiary of Eli Lilly and Company), Philadelphia, PA, USA
– sequence: 11
  givenname: Bradley B.
  surname: Miller
  fullname: Miller, Bradley B.
  organization: Eli Lilly and Company, Indianapolis, IN, USA
– sequence: 12
  givenname: Andrew J.
  surname: Saykin
  fullname: Saykin, Andrew J.
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29780867$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1v1DAQhiNUREvpH-CAcuSyYewk_pBQpdLyUVTEpZwtZzJJvcrGwc4W7b_HS1rUcqg4jD0az_uMNe_L7GD0I2XZawYFAyberYvWtpuCA1MFsAJAPMuOeFnzlZJcHzzID7OTGNcAwCrNKwYvskOupQIl5FF2eu0n3wc73TjM42x7N_a57_LZbvPJRzcHP-a0cTG6lMx-szTvcrexPcVX2fPODpFO7u7j7Menj9fnX1ZX3z9fnp9drbBWWqw0dlh1qBlnFZNUM8SygRSNBStkUyEozVBLFMg6LZpGK05Nk9QVSa7K4-xy4bbers0U0vSwM94686fgQ29smB0OZEh2KEoOgMQq6piWUjW8lm0puq7iTWKdLqxp22yoRRrnYIdH0Mcvo7sxvb81ta6FAkiAt3eA4H9uKc4m7QdpGOxIfhsNh4rzMoVIrW8ezvo75N6A1KCWBgw-xkCdQTfbOS07jXaDYWD2dpu12dtt9nYbYCbZnaT8H-k9_UnRh0X0yw20-w-FuTi74F_T8W1fBLZA3i8QSpbfOgomoqMRqXWBcE6euKf-8BucldfC
CitedBy_id crossref_primary_10_1007_s40336_018_0297_4
crossref_primary_10_1016_j_neuroimage_2024_120593
crossref_primary_10_1007_s40336_018_0290_y
crossref_primary_10_1007_s11011_021_00733_4
crossref_primary_10_1001_jamaneurol_2022_2793
crossref_primary_10_1002_alz_13859
crossref_primary_10_1159_000507569
crossref_primary_10_1016_j_mednuc_2022_05_001
crossref_primary_10_1016_j_nicl_2019_101958
crossref_primary_10_3389_fnagi_2022_926904
crossref_primary_10_1016_j_neulet_2023_137591
crossref_primary_10_1001_jamaneurol_2019_1971
crossref_primary_10_1088_2399_6528_ac7d3a
crossref_primary_10_1016_j_neuroimage_2020_117560
crossref_primary_10_3233_ADR_210296
crossref_primary_10_1002_alz_13483
crossref_primary_10_2967_jnumed_123_265941
crossref_primary_10_1007_s00259_019_04536_9
crossref_primary_10_1093_brain_awae211
crossref_primary_10_1186_s13195_022_00986_w
crossref_primary_10_1007_s00259_021_05391_3
crossref_primary_10_3233_JAD_230512
crossref_primary_10_1093_brain_awad042
crossref_primary_10_3389_fnins_2023_1089134
crossref_primary_10_3389_fnins_2022_1042865
crossref_primary_10_1016_j_jocn_2019_07_001
crossref_primary_10_1186_s13195_023_01160_6
crossref_primary_10_1212_WNL_0000000000207250
crossref_primary_10_2967_jnumed_119_230458
crossref_primary_10_3389_fnmol_2019_00107
crossref_primary_10_1093_braincomms_fcad305
crossref_primary_10_3389_fnagi_2020_00093
crossref_primary_10_1016_j_neuroimage_2021_118126
crossref_primary_10_1080_13825585_2022_2120957
crossref_primary_10_1177_1073858421997035
crossref_primary_10_3389_fmed_2023_1168470
crossref_primary_10_2967_jnumed_120_245423
crossref_primary_10_1038_s41398_021_01602_5
Cites_doi 10.1016/S1474-4422(10)70223-4
10.1007/s00401-014-1349-0
10.1002/ana.24825
10.1007/s00330-015-3696-1
10.1212/WNL.58.12.1791
10.1212/WNL.52.6.1158
10.1212/WNL.0000000000002923
10.1001/archneurol.2011.183
10.1016/j.jalz.2011.03.008
10.1016/S1474-4422(12)70291-0
10.1097/WAD.0000000000000196
10.1016/S1474-4422(14)70252-2
10.1007/s00259-015-3231-2
10.1016/j.jalz.2011.03.005
10.1186/s13024-017-0162-3
10.1186/2051-5960-1-65
10.1016/S1474-4422(11)70156-9
10.1002/hbm.22927
10.1001/jamaneurol.2016.5953
10.1007/BF00308809
10.1016/j.neuroimage.2017.05.058
10.1002/ana.22628
10.1016/j.neuron.2016.01.028
10.1016/j.dadm.2016.12.010
10.1093/brain/aww027
10.1093/brain/awx171
10.1007/s00401-006-0127-z
10.1002/ana.24546
10.1007/s00401-011-0910-3
10.1016/j.jalz.2011.03.003
10.1002/ana.24711
10.1093/brain/aww023
ContentType Journal Article
Copyright 2018 The Authors
2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
2018 The Authors 2018
Copyright_xml – notice: 2018 The Authors
– notice: 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
– notice: 2018 The Authors 2018
CorporateAuthor Alzheimer's Disease Neuroimaging Initiative
CorporateAuthor_xml – name: Alzheimer's Disease Neuroimaging Initiative
DBID 6I.
AAFTH
24P
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1016/j.dadm.2018.01.006
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Wiley Online Library Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2352-8729
EndPage 231
ExternalDocumentID oai_doaj_org_article_e7fc63200ce14ef19778b257d36ff42b
PMC5956800
29780867
10_1016_j_dadm_2018_01_006
DAD2JDADM201801006
S235287291830006X
Genre article
Journal Article
GrantInformation_xml – fundername: NIH
  funderid: P30 AG010133
– fundername: NIH
  funderid: U01 AG032984
– fundername: NIA NIH HHS
  grantid: K01 AG049050
GroupedDBID 0R~
0SF
1OC
24P
457
53G
6I.
7RV
7X7
8FI
8FJ
AACTN
AAEDW
AAFTH
AAHHS
AALRI
AAXUO
ABMAC
ABUWG
ACCFJ
ACGFS
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AEQDE
AEVXI
AEXQZ
AFKRA
AFTJW
AGHFR
AITUG
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
AVUZU
BAWUL
BENPR
CCPQU
EBS
EJD
EMOBN
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
INH
KQ8
M48
M~E
NAPCQ
NCXOZ
O9-
OK1
OVD
OVEED
PIMPY
ROL
RPM
SSZ
TEORI
UKHRP
WIN
ACCMX
ADVLN
ALIPV
ALUQN
IHR
ITC
AAYWO
AAYXX
CITATION
PHGZM
PHGZT
NPM
PPXIY
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5896-9cfc4fc9121417e51cc3b0c3bba0a67b4c0891c97c6c1f96bb982ebbc584e7283
IEDL.DBID M48
ISSN 2352-8729
IngestDate Wed Aug 27 00:34:22 EDT 2025
Thu Aug 21 18:06:36 EDT 2025
Thu Jul 10 16:59:02 EDT 2025
Mon Jul 21 06:04:27 EDT 2025
Tue Jul 01 02:13:33 EDT 2025
Thu Apr 24 22:56:31 EDT 2025
Wed Jan 22 16:34:38 EST 2025
Fri Feb 23 02:47:30 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords AV-1451
Flortaucipir
Staging
Classification
Tau
Stage
Image
Braak
T807
Alzheimer
PET
Language English
License This is an open access article under the CC BY-NC-ND license.
Attribution-NonCommercial-NoDerivs
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5896-9cfc4fc9121417e51cc3b0c3bba0a67b4c0891c97c6c1f96bb982ebbc584e7283
Notes http://adni.loni.usc.edu/wp‐content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at
Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database
adni.loni.usc.edu
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.dadm.2018.01.006
PMID 29780867
PQID 2042234226
PQPubID 23479
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_e7fc63200ce14ef19778b257d36ff42b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5956800
proquest_miscellaneous_2042234226
pubmed_primary_29780867
crossref_citationtrail_10_1016_j_dadm_2018_01_006
crossref_primary_10_1016_j_dadm_2018_01_006
wiley_primary_10_1016_j_dadm_2018_01_006_DAD2JDADM201801006
elsevier_sciencedirect_doi_10_1016_j_dadm_2018_01_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Alzheimer's & dementia : diagnosis, assessment & disease monitoring
PublicationTitleAlternate Alzheimers Dement (Amst)
PublicationYear 2018
Publisher Elsevier Inc
Elsevier
Wiley
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Wiley
References Schöll, Lockhart, Schonhaut, O'Neil, Janabi, Ossenkoppele (bib11) 2016; 89
Day, Gordon, Jackson, Christensen, Ponisio, Su (bib28) 2017; 31
Dani, Brooks, Edison (bib8) 2016; 43
Dubois, Feldman, Jacova, Cummings, Dekosky, Barberger-Gateau (bib20) 2010; 9
Jack, Bennett, Blennow, Carrillo, Feldman, Frisoni (bib16) 2016; 87
Verfaillie, Adriaanse, Binnewijzend, Benedictus, Ossenkoppele, Wattjes (bib34) 2015; 25
Devous, Joshi, Navitsky, Southekal, Pontecorvo, Siderowf (bib24) 2017
Murray, Graff-Radford, Ross, Petersen, Duara, Dickson (bib32) 2011; 10
Jack, Knopman, Weigand, Wiste, Vemuri, Lowe (bib21) 2012; 71
Ossenkoppele, Cohn-Sheehy, La Joie, Vogel, Moller, Lehmann (bib33) 2015; 36
Jack, Vemuri, Wiste, Weigand, Aisen, Trojanowski (bib17) 2011; 68
Toledo, Cairns, Da, Chen, Carter, Fleisher (bib30) 2013; 1
Albert, DeKosky, Dickson, Dubois, Feldman, Fox (bib18) 2011; 7
Cho, Choi, Hwang, Kim, Lee, Lee (bib12) 2016; 80
Kantarci, Lowe, Boeve, Senjem, Tosakulwong, Lesnick (bib29) 2017; 81
Crary, Trojanowski, Schneider, Abisambra, Abner, Alafuzoff (bib26) 2014; 128
Scholl, Ossenkoppele, Strandberg, Palmqvist, Jogi, Ohlsson (bib35) 2017; 140
Delacourte, David, Sergeant, Buee, Wattez, Vermersch (bib5) 1999; 52
Sperling, Aisen, Beckett, Bennett, Craft, Fagan (bib14) 2011; 7
Southekal, Devous, Kennedy (bib31) 2017
Qian, Hyman, Betensky (bib23) 2017; 74
Ossenkoppele, Schonhaut, Scholl, Lockhart, Ayakta, Baker (bib27) 2016; 139
Braak, Braak (bib1) 1991; 82
Vemuri, Lowe, Knopman, Senjem, Kemp, Schwarz (bib25) 2017; 6
Montine, Phelps, Beach, Bigio, Cairns, Dickson (bib3) 2012; 123
Saint-Aubert, Lemoine, Chiotis, Leuzy, Rodriguez-Vieitez, Nordberg (bib7) 2017; 12
Jack, Knopman, Jagust, Petersen, Weiner, Aisen (bib15) 2013; 12
McKhann, Knopman, Chertkow, Hyman, Jack, Kawas (bib19) 2011; 7
Maass, Landau, Baker, Horng, Lockhart, La Joie (bib22) 2017; 157
Thal, Rub, Orantes, Braak (bib2) 2002; 58
Pontecorvo, Devous, Navitsky, Lu, Salloway, Schaerf (bib13) 2017; 140
Johnson, Schultz, Betensky, Becker, Sepulcre, Rentz (bib9) 2016; 79
Villemagne, Fodero-Tavoletti, Masters, Rowe (bib6) 2015; 14
Braak, Alafuzoff, Arzberger, Kretzschmar, Del Tredici (bib4) 2006; 112
Schwarz, Yu, Miller, Shcherbinin, Dickson, Navitsky (bib10) 2016; 139
2017; 6
2002; 58
2015; 14
2015; 36
2012; 123
2013; 1
2017; 81
1991; 82
2011; 10
2017; 157
2006; 112
2016; 79
2011; 7
2012; 71
2017; 31
2017; 74
2014; 128
2015; 25
2013; 12
2017; 12
2016; 43
2016; 87
2017
2016; 139
2017; 140
2011; 68
1999; 52
2016; 80
2016; 89
2010; 9
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
Ossenkoppele R. (e_1_2_7_28_1) 2016; 139
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
Pontecorvo M.J. (e_1_2_7_14_1) 2017; 140
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
Devous M.D. (e_1_2_7_25_1) 2017
e_1_2_7_27_1
e_1_2_7_29_1
e_1_2_7_30_1
Southekal S. (e_1_2_7_32_1) 2017
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
References_xml – volume: 7
  start-page: 263
  year: 2011
  end-page: 269
  ident: bib19
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 14
  start-page: 114
  year: 2015
  end-page: 124
  ident: bib6
  article-title: Tau imaging: early progress and future directions
  publication-title: Lancet Neurol
– volume: 36
  start-page: 4421
  year: 2015
  end-page: 4437
  ident: bib33
  article-title: Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease
  publication-title: Hum Brain Mapp
– volume: 82
  start-page: 239
  year: 1991
  end-page: 259
  ident: bib1
  article-title: Neuropathological stageing of Alzheimer-related changes
  publication-title: Acta Neuropathol
– volume: 112
  start-page: 389
  year: 2006
  end-page: 404
  ident: bib4
  article-title: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
  publication-title: Acta Neuropathol
– volume: 43
  start-page: 1139
  year: 2016
  end-page: 1150
  ident: bib8
  article-title: Tau imaging in neurodegenerative diseases
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 79
  start-page: 110
  year: 2016
  end-page: 119
  ident: bib9
  article-title: Tau PET imaging in aging and early Alzheimer's disease
  publication-title: Ann Neurol
– volume: 139
  start-page: 1539
  year: 2016
  end-page: 1550
  ident: bib10
  article-title: Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
  publication-title: Brain
– volume: 81
  start-page: 58
  year: 2017
  end-page: 67
  ident: bib29
  article-title: AV-1451 tau and beta-Amyloid PET imaging in dementia with lewy bodies
  publication-title: Ann Neurol
– volume: 12
  start-page: 207
  year: 2013
  end-page: 216
  ident: bib15
  article-title: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
  publication-title: Lancet Neurol
– volume: 68
  start-page: 1526
  year: 2011
  end-page: 1535
  ident: bib17
  article-title: Evidence for ordering of Alzheimer disease biomarkers
  publication-title: Arch Neurol
– volume: 71
  start-page: 765
  year: 2012
  end-page: 775
  ident: bib21
  article-title: An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
  publication-title: Ann Neurol
– year: 2017
  ident: bib24
  article-title: Test-retest reproducibility for the tau PET imaging agent Flortaucipir F 18 [published online ahead of print December 28, 2017]
  publication-title: J Nucl Med
– volume: 10
  start-page: 785
  year: 2011
  end-page: 796
  ident: bib32
  article-title: Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
  publication-title: Lancet Neurol
– volume: 52
  start-page: 1158
  year: 1999
  end-page: 1165
  ident: bib5
  article-title: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
  publication-title: Neurology
– volume: 139
  start-page: 1551
  year: 2016
  end-page: 1567
  ident: bib27
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
  publication-title: Brain
– volume: 140
  start-page: 748
  year: 2017
  end-page: 763
  ident: bib13
  article-title: Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
  publication-title: Brain
– volume: 157
  start-page: 448
  year: 2017
  end-page: 463
  ident: bib22
  article-title: Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
  publication-title: NeuroImage
– volume: 6
  start-page: 21
  year: 2017
  end-page: 30
  ident: bib25
  article-title: Tau-PET uptake: regional variation in average SUVR and impact of amyloid deposition
  publication-title: Alzheimers Dement (Amst)
– volume: 25
  start-page: 3050
  year: 2015
  end-page: 3059
  ident: bib34
  article-title: Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
  publication-title: Eur Radiol
– volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  ident: bib18
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 87
  start-page: 539
  year: 2016
  end-page: 547
  ident: bib16
  article-title: A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
  publication-title: Neurology
– year: 2017
  ident: bib31
  article-title: Flortaucipir F 18 quantitation using a Parametric Estimate of Reference Signal Intensity (PERSI) [published online ahead of print November 30, 2017]
  publication-title: J Nucl Med
– volume: 58
  start-page: 1791
  year: 2002
  end-page: 1800
  ident: bib2
  article-title: Phases of Abeta-deposition in the human brain and its relevance for the development of AD
  publication-title: Neurology
– volume: 1
  start-page: 65
  year: 2013
  ident: bib30
  article-title: Clinical and multimodal biomarker correlates of ADNI neuropathological findings
  publication-title: Acta Neuropathol Commun
– volume: 7
  start-page: 280
  year: 2011
  end-page: 292
  ident: bib14
  article-title: Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 123
  start-page: 1
  year: 2012
  end-page: 11
  ident: bib3
  article-title: National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
  publication-title: Acta Neuropathol
– volume: 12
  start-page: 19
  year: 2017
  ident: bib7
  article-title: Tau PET imaging: present and future directions
  publication-title: Mol Neurodegener
– volume: 80
  start-page: 247
  year: 2016
  end-page: 258
  ident: bib12
  article-title: In vivo cortical spreading pattern of tau and amyloid in the Alzheimer's disease spectrum
  publication-title: Ann Neurol
– volume: 31
  start-page: 87
  year: 2017
  end-page: 93
  ident: bib28
  article-title: Tau-PET binding distinguishes patients with early-stage posterior cortical atrophy from amnestic Alzheimer disease dementia
  publication-title: Alzheimer Dis Assoc Disord
– volume: 74
  start-page: 540
  year: 2017
  end-page: 548
  ident: bib23
  article-title: Neurofibrillary tangle stage and the rate of progression of Alzheimer symptoms: modeling using an autopsy cohort and application to clinical trial design
  publication-title: JAMA Neurol
– volume: 9
  start-page: 1118
  year: 2010
  end-page: 1127
  ident: bib20
  article-title: Revising the definition of Alzheimer's disease: a new lexicon
  publication-title: Lancet Neurol
– volume: 89
  start-page: 971
  year: 2016
  end-page: 982
  ident: bib11
  article-title: PET imaging of tau deposition in the aging human brain
  publication-title: Neuron
– volume: 128
  start-page: 755
  year: 2014
  end-page: 766
  ident: bib26
  article-title: Primary age-related tauopathy (PART): a common pathology associated with human aging
  publication-title: Acta Neuropathol
– volume: 140
  start-page: 2286
  year: 2017
  end-page: 2294
  ident: bib35
  article-title: Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
  publication-title: Brain
– volume: 14
  start-page: 114
  year: 2015
  end-page: 124
  article-title: Tau imaging: early progress and future directions
  publication-title: Lancet Neurol
– volume: 74
  start-page: 540
  year: 2017
  end-page: 548
  article-title: Neurofibrillary tangle stage and the rate of progression of Alzheimer symptoms: modeling using an autopsy cohort and application to clinical trial design
  publication-title: JAMA Neurol
– volume: 12
  start-page: 19
  year: 2017
  article-title: Tau PET imaging: present and future directions
  publication-title: Mol Neurodegener
– volume: 7
  start-page: 280
  year: 2011
  end-page: 292
  article-title: Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 10
  start-page: 785
  year: 2011
  end-page: 796
  article-title: Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
  publication-title: Lancet Neurol
– volume: 71
  start-page: 765
  year: 2012
  end-page: 775
  article-title: An operational approach to National Institute on Aging‐Alzheimer's Association criteria for preclinical Alzheimer disease
  publication-title: Ann Neurol
– volume: 9
  start-page: 1118
  year: 2010
  end-page: 1127
  article-title: Revising the definition of Alzheimer's disease: a new lexicon
  publication-title: Lancet Neurol
– volume: 36
  start-page: 4421
  year: 2015
  end-page: 4437
  article-title: Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease
  publication-title: Hum Brain Mapp
– volume: 68
  start-page: 1526
  year: 2011
  end-page: 1535
  article-title: Evidence for ordering of Alzheimer disease biomarkers
  publication-title: Arch Neurol
– volume: 25
  start-page: 3050
  year: 2015
  end-page: 3059
  article-title: Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?
  publication-title: Eur Radiol
– volume: 6
  start-page: 21
  year: 2017
  end-page: 30
  article-title: Tau‐PET uptake: regional variation in average SUVR and impact of amyloid deposition
  publication-title: Alzheimers Dement (Amst)
– volume: 1
  start-page: 65
  year: 2013
  article-title: Clinical and multimodal biomarker correlates of ADNI neuropathological findings
  publication-title: Acta Neuropathol Commun
– volume: 112
  start-page: 389
  year: 2006
  end-page: 404
  article-title: Staging of Alzheimer disease‐associated neurofibrillary pathology using paraffin sections and immunocytochemistry
  publication-title: Acta Neuropathol
– volume: 79
  start-page: 110
  year: 2016
  end-page: 119
  article-title: Tau PET imaging in aging and early Alzheimer's disease
  publication-title: Ann Neurol
– volume: 58
  start-page: 1791
  year: 2002
  end-page: 1800
  article-title: Phases of Abeta‐deposition in the human brain and its relevance for the development of AD
  publication-title: Neurology
– volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 43
  start-page: 1139
  year: 2016
  end-page: 1150
  article-title: Tau imaging in neurodegenerative diseases
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 31
  start-page: 87
  year: 2017
  end-page: 93
  article-title: Tau‐PET binding distinguishes patients with early‐stage posterior cortical atrophy from amnestic Alzheimer disease dementia
  publication-title: Alzheimer Dis Assoc Disord
– volume: 139
  start-page: 1551
  issue: (Pt 5)
  year: 2016
  end-page: 1567
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
  publication-title: Brain
– volume: 80
  start-page: 247
  year: 2016
  end-page: 258
  article-title: In vivo cortical spreading pattern of tau and amyloid in the Alzheimer's disease spectrum
  publication-title: Ann Neurol
– volume: 81
  start-page: 58
  year: 2017
  end-page: 67
  article-title: AV‐1451 tau and beta‐Amyloid PET imaging in dementia with lewy bodies
  publication-title: Ann Neurol
– year: 2017
  article-title: Flortaucipir F 18 quantitation using a Parametric Estimate of Reference Signal Intensity (PERSI) [published online ahead of print November 30, 2017]
  publication-title: J Nucl Med
– volume: 123
  start-page: 1
  year: 2012
  end-page: 11
  article-title: National Institute on Aging‐Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
  publication-title: Acta Neuropathol
– volume: 140
  start-page: 748
  year: 2017
  end-page: 763
  article-title: Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
  publication-title: Brain
– volume: 7
  start-page: 263
  year: 2011
  end-page: 269
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 89
  start-page: 971
  year: 2016
  end-page: 982
  article-title: PET imaging of tau deposition in the aging human brain
  publication-title: Neuron
– volume: 128
  start-page: 755
  year: 2014
  end-page: 766
  article-title: Primary age‐related tauopathy (PART): a common pathology associated with human aging
  publication-title: Acta Neuropathol
– volume: 82
  start-page: 239
  year: 1991
  end-page: 259
  article-title: Neuropathological stageing of Alzheimer‐related changes
  publication-title: Acta Neuropathol
– volume: 52
  start-page: 1158
  year: 1999
  end-page: 1165
  article-title: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
  publication-title: Neurology
– volume: 140
  start-page: 2286
  year: 2017
  end-page: 2294
  article-title: Distinct 18F‐AV‐1451 tau PET retention patterns in early‐ and late‐onset Alzheimer's disease
  publication-title: Brain
– volume: 157
  start-page: 448
  year: 2017
  end-page: 463
  article-title: Comparison of multiple tau‐PET measures as biomarkers in aging and Alzheimer's disease
  publication-title: NeuroImage
– volume: 12
  start-page: 207
  year: 2013
  end-page: 216
  article-title: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
  publication-title: Lancet Neurol
– volume: 87
  start-page: 539
  year: 2016
  end-page: 547
  article-title: A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
  publication-title: Neurology
– volume: 139
  start-page: 1539
  year: 2016
  end-page: 1550
  article-title: Regional profiles of the candidate tau PET ligand 18F‐AV‐1451 recapitulate key features of Braak histopathological stages
  publication-title: Brain
– year: 2017
  article-title: Test‐retest reproducibility for the tau PET imaging agent Flortaucipir F 18 [published online ahead of print December 28, 2017]
  publication-title: J Nucl Med
– ident: e_1_2_7_21_1
  doi: 10.1016/S1474-4422(10)70223-4
– ident: e_1_2_7_27_1
  doi: 10.1007/s00401-014-1349-0
– ident: e_1_2_7_30_1
  doi: 10.1002/ana.24825
– ident: e_1_2_7_35_1
  doi: 10.1007/s00330-015-3696-1
– ident: e_1_2_7_3_1
  doi: 10.1212/WNL.58.12.1791
– ident: e_1_2_7_6_1
  doi: 10.1212/WNL.52.6.1158
– ident: e_1_2_7_17_1
  doi: 10.1212/WNL.0000000000002923
– ident: e_1_2_7_18_1
  doi: 10.1001/archneurol.2011.183
– ident: e_1_2_7_19_1
  doi: 10.1016/j.jalz.2011.03.008
– ident: e_1_2_7_16_1
  doi: 10.1016/S1474-4422(12)70291-0
– ident: e_1_2_7_29_1
  doi: 10.1097/WAD.0000000000000196
– ident: e_1_2_7_7_1
  doi: 10.1016/S1474-4422(14)70252-2
– ident: e_1_2_7_9_1
  doi: 10.1007/s00259-015-3231-2
– ident: e_1_2_7_20_1
  doi: 10.1016/j.jalz.2011.03.005
– ident: e_1_2_7_8_1
  doi: 10.1186/s13024-017-0162-3
– year: 2017
  ident: e_1_2_7_25_1
  article-title: Test‐retest reproducibility for the tau PET imaging agent Flortaucipir F 18 [published online ahead of print December 28, 2017]
  publication-title: J Nucl Med
– ident: e_1_2_7_31_1
  doi: 10.1186/2051-5960-1-65
– ident: e_1_2_7_33_1
  doi: 10.1016/S1474-4422(11)70156-9
– ident: e_1_2_7_34_1
  doi: 10.1002/hbm.22927
– ident: e_1_2_7_24_1
  doi: 10.1001/jamaneurol.2016.5953
– ident: e_1_2_7_2_1
  doi: 10.1007/BF00308809
– ident: e_1_2_7_23_1
  doi: 10.1016/j.neuroimage.2017.05.058
– ident: e_1_2_7_22_1
  doi: 10.1002/ana.22628
– ident: e_1_2_7_12_1
  doi: 10.1016/j.neuron.2016.01.028
– ident: e_1_2_7_26_1
  doi: 10.1016/j.dadm.2016.12.010
– volume: 139
  start-page: 1551
  issue: 5
  year: 2016
  ident: e_1_2_7_28_1
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
  publication-title: Brain
  doi: 10.1093/brain/aww027
– ident: e_1_2_7_36_1
  doi: 10.1093/brain/awx171
– ident: e_1_2_7_5_1
  doi: 10.1007/s00401-006-0127-z
– ident: e_1_2_7_10_1
  doi: 10.1002/ana.24546
– ident: e_1_2_7_4_1
  doi: 10.1007/s00401-011-0910-3
– ident: e_1_2_7_15_1
  doi: 10.1016/j.jalz.2011.03.003
– volume: 140
  start-page: 748
  year: 2017
  ident: e_1_2_7_14_1
  article-title: Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
  publication-title: Brain
– year: 2017
  ident: e_1_2_7_32_1
  article-title: Flortaucipir F 18 quantitation using a Parametric Estimate of Reference Signal Intensity (PERSI) [published online ahead of print November 30, 2017]
  publication-title: J Nucl Med
– ident: e_1_2_7_13_1
  doi: 10.1002/ana.24711
– ident: e_1_2_7_11_1
  doi: 10.1093/brain/aww023
SSID ssj0001492410
Score 2.303095
Snippet It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages similar to those...
Introduction It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic stages...
Abstract Introduction It has been proposed that the signal distribution on tau positron emission tomography (PET) images could be used to define pathologic...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 221
SubjectTerms Alzheimer
AV-1451
Braak
Classification
Flortaucipir
PET
Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Stage
Staging
T807
Tau
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlp15KS9vUbVpU6K2YaryyLFEo5JMQSE4J5CassUQ3NHZIdv9_Zyzvsksg6aEH-2BLsj0z1jzZM2-E-KY0amwRSyRMVOrgsLRYQRl0lxAg0bTMucPnF-b0Sp9d19cbpb44JizTA2fB_YhNQjMjXWIEHRMQXrGB7KybmZR0FXj2JZ-3sZi6ybifXJOasmRyQFfXdpx6Dnbk6eQSRxueaCTs33JIjwHn47jJTTw7OqST1-LVhCTlfn6CN-JF7N-KX5fDXSahnqMk4McliOSQ5KJdyjE-637oJZd4449kcjHcTozVcn5LE8vDO3F1cnx5eFpOJRJKrK0zpcOEOqGDCjQ0sQbEWVC0hVa1pgkalXWArkGDkJwJwdkqhkC9dWwIWrwXO_3Qxw9CkmRmbVdDIACgXUe4xSZSIAToLOOaQsBKXB4n_nAuY_HHrwLFbjyL2LOIvQJPIi7E93Wfu8ye8WTrA9bCuiUzX48HyB78ZA_-OXsoRL3SoZ9ARAYHNNT8yYt_XSnckxb4t0nbx2H5QI00YSjOOC7EbjaA9S1WTOBkTVOIZss0tp5h-0w__z2yeNecqKlUIX6ORvQP8vFH-0fVGe3O-SAtpJX5-D9E9km85AHzh6U9sbO4X8bPBLUW4cv4Vv0FtrslRg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9UwFA5je_FFHE6tmxLBNyk0uWmaIAjT6xiDiQ8b7C00p4ne4dpxf_z_npO2d-sGQ_ChpaRJ2p6Tc_IlzfnC2MdCgYIaIAfERLnyFnIDUuReNRGEiOiWKXb4_Ic-vVRnV-XVDpuPsTA9P8R2wo0sI_lrMvDar-6NN69xSNxQLLkwiXiTeLf3KMaWGPSl-nk306JwjJFoCSSiDTR_aYfomX6h18NqJj1UIvKfdFSPgejj9ZT3cW7qqE5esOcDwuTHfZPYZzuhfcm-XHS3PTn1AjgCQtqaiHeRr-sNT-u2ll3Laes3mjzj6-5mYLLmixt0OKsDdnny_eLbaT5snZBDaazOLURQEayQQokqlAJg5gs8fF3UuvIKCmMF2Ao0iGi199bI4D2WVqFCyPGK7bZdG94wjpKZ1U0pPAIDZRvEMyaiYoUXjSG8kzExisvBwCtO21v8ceMCsmtHInYkYlcIhyLO2KdtmdueVePJ3F9JC9ucxIidErrlLzcYmAtVBD1Dm4cgVIgCca3x6I-amY5RSZ-xctShG8BFDxqwqsWTD_8wKtyhFuh3St2GbrPCTAqxFUUiZ-x13wC2ryiJ2MnoKmPVpGlMvmF6p138TuzeJQVwFkXGPqdG9A_ycfPjuTzD0zkl4gC70G__q_Qhe0bX_UzTEdtdLzfhHWKvtX-fTOsvJVAllw
  priority: 102
  providerName: Wiley-Blackwell
Title Topographic staging of tau positron emission tomography images
URI https://dx.doi.org/10.1016/j.dadm.2018.01.006
https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.dadm.2018.01.006
https://www.ncbi.nlm.nih.gov/pubmed/29780867
https://www.proquest.com/docview/2042234226
https://pubmed.ncbi.nlm.nih.gov/PMC5956800
https://doaj.org/article/e7fc63200ce14ef19778b257d36ff42b
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7S5NJLaenLfSwu9FZcLK_8EKEtSZMQAhtCycLehDWW2g2JnewD2n_fGdne1iSE0oMFlmXZntFIn2TNNwDvY4kSS8QICRNF0iiMCkxEZGTlUAhH3TL7Dk9Os-OpPJmlsy3owx11AlzeObXjeFLTxeXHnze_vpDBf_qzV6sqK_YqF4Wn4GQG7h0amXI21EkH9y_a2QBlxz7eXModQaI6P5q7qxmMVZ7SfzBk3Yakt3dW_o14_ZB19BgedVgz3GsbxxPYsvVT-HzeXLc01XMMCRpykKKwceGqXId-B9eiqUMOAsfLaOGqueo4rcP5FXU9y2cwPTo8_3ocdUEUIkwLlUUKHUqHSiSCJGJTgTg2MR2mjMssNxLjQglUOWYonMqMUUVijaG7pc0JfDyH7bqp7UsISTLjskqFIYggVUXIpnCkYmFEVTDyCUD04tLYMYxzoItL3W8lu9AsYs0i1rHQJOIAPmzuuW75Ne4tvc9a2JRkbmyf0Sy-687UtM0dZmOyfrRCWicI4RaGeqZqnDknExNA2utQdzCjhQ9U1fzeh7_rFa5JC_xjpaxts15SIUkoi32SA3jRNoDNKyZM8VRkeQD5oGkMvmF4pZ7_8DzfKbtyxnEAu74R_YN89MHeQXJCyYQzaaodZ6_-82tfw0M-a1eb3sD2arG2bwl_rcwIHiTyjNJ8lo9gZ__w9OzbyK9ljLy5_QbpJy82
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBYhObSX0tKX-0hd6K0YLK0sSxQKebJNs6GHDeQmrLHUbGjssNn9_52R7W3cQCj0YB9kyY8ZjfTNWPOJsU-5BAkVQAaIiTLpDGQaBM-crANwHnBYptzh2ZmansuTi-Jiix0NuTAdP8Qm4EaWEcdrMnAKSN9xOK_QJ64pmZzryLxJxNs7UomS7FPIH39CLRKdjMhLIBBuoP0L06fPdCu9_r7NaIqKTP6jmeo-Er2_oPIu0I0z1fFT9qSHmOle1yeesS3fPGdf5-1Nx069gBQRIe1NlLYhXVXrNC7cWrZNSnu_UfQsXbXXPZV1urjGEef2BTs_PpofTLN-74QMCm1UZiCADGC44JKXvuAAE5fj4aq8UqWTkGvDwZSggAejnDNaeOewtfQlYo6XbLtpG_-apSiZSVUX3CEykKZGQKMDapY7XmsCPAnjg7gs9MTitL_FLzusILuyJGJLIrY5tyjihH3etLnpaDUerL1PWtjUJErsWNAuf9rewqwvA6gJGj14Ln3gCGy1wwGpnqgQpHAJKwYd2h5ddKgBb7V48OEfB4Vb1AL9T6ka365vsZJEcEWpyAl71XWAzSsKYnbSqkxYOeoao28YX2kWl5Heu6AMzjxP2JfYif5BPvZw71Cc4GlGhehh5-rNf7X-wB5N57NTe_rt7Ptb9pjKu7DTO7a9Wq79ewRiK7cbzew3-KEpAw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFA7LLogvonir1wi-SaHppGmCIIyOw7q6iw87svgSmtNEZ3HbYXbm_3tO2o5bFxbBh_YhTXo5t3xJc74w9jqTIKECSAExUSqdgVRDLlIn6wBCBAzLlDt8fKIOF_LorDjbY7MhF6bjh9hNuJFnxHhNDr6qw5Xx5jkOiWvKJRc6Em8S7_YB0eWhbR9Mvy2-L_7MtUgcZURighzxBgaA3PT5M91Sr79vNOqjIpX_qKu6DkWvr6i8inRjVzW_y-70GJNPO6O4x_Z8c5-9O21XHT31EjhCQtqciLeBb6otjyu31m3DafM3mj7jm_ai57LmywsMOZcP2GL-8fTDYdpvnpBCoY1KDQSQAYzIhRSlLwTAxGV4uCqrVOkkZNoIMCUoEMEo54zOvXPYWvoSQcdDtt-0jX_MOEpmUtWFcAgNpKkR0eiAqhVO1JoQT8LEIC4LPbM4bXDxyw5LyM4tidiSiG0mLIo4YW92bVYdr8aNtd-TFnY1iRM7FrTrH7Z3MevLAGqCXg9eSB8EIlvtMCLVExWCzF3CikGHtocXHWzAWy1vfPirQeEWtUA_VKrGt9tLrCQRXVEucsIedQawe8WcqJ20KhNWjkxj9A3jK83yZ-T3LiiFM8sS9jYa0T_Ix86ms_wIT8dUiEPsTD35r9Yv2a2vs7n98unk81N2m4q7aadnbH-z3vrnCMQ27kXvZ78Bqwcp-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Topographic+staging+of+tau+positron+emission+tomography+images&rft.jtitle=Alzheimer%27s+%26+dementia+%3A+diagnosis%2C+assessment+%26+disease+monitoring&rft.au=Schwarz%2C+Adam+J.&rft.au=Shcherbinin%2C+Sergey&rft.au=Slieker%2C+Lawrence+J.&rft.au=Risacher%2C+Shannon+L.&rft.date=2018&rft.pub=Elsevier+Inc&rft.issn=2352-8729&rft.eissn=2352-8729&rft.volume=10&rft.spage=221&rft.epage=231&rft_id=info:doi/10.1016%2Fj.dadm.2018.01.006&rft.externalDocID=S235287291830006X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-8729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-8729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-8729&client=summon